BACKGROUND: Wild golden lion tamarins from the Biological Reserve of Poço das Antas, Rio de Janeiro, Brazil, have high prevalence of Trypanosoma cruzi infection leading us to clinically assess the disease in this endangered species. METHODS: 34 tamarins were sampled for the presence of T. cruzi infection (through serology) and clinical evaluation (electrocardiography, blood counts and biochemical analysis). RESULTS: 32% of the sampled tamarins were T. cruzi positive, 45% of these displayed cardiac abnormalities. Main cardiac abnormality in infected tamarins was T wave low voltage; R wave low voltage and V3S wave high voltage were also found. The tamarins displaying T wave low voltage had high proportion of seric cardiac creatine kinase. Seric mean total protein was significantly higher in infected tamarins. CONCLUSIONS: Sampled tamarins displayed typical signs of T. cruzi infection, similar to experimentally infected primates and human natural infection. Potential risk of T. cruzi infection to this endangered species is discussed.
BACKGROUND: Wild golden lion tamarins from the Biological Reserve of Poço das Antas, Rio de Janeiro, Brazil, have high prevalence of Trypanosoma cruzi infection leading us to clinically assess the disease in this endangered species. METHODS: 34 tamarins were sampled for the presence of T. cruzi infection (through serology) and clinical evaluation (electrocardiography, blood counts and biochemical analysis). RESULTS: 32% of the sampled tamarins were T. cruzi positive, 45% of these displayed cardiac abnormalities. Main cardiac abnormality in infected tamarins was T wave low voltage; R wave low voltage and V3S wave high voltage were also found. The tamarins displaying T wave low voltage had high proportion of seric cardiac creatine kinase. Seric mean total protein was significantly higher in infected tamarins. CONCLUSIONS: Sampled tamarins displayed typical signs of T. cruzi infection, similar to experimentally infected primates and human natural infection. Potential risk of T. cruzi infection to this endangered species is discussed.
Authors: Rafael V Monteiro; James M Dietz; Becky Raboy; Benjamin Beck; Kristel De Vleeschouwer; Kristel D Vleeschouwer; Andrew Baker; Andréia Martins; Ana Maria Jansen Journal: Parasitol Res Date: 2007-08-04 Impact factor: 2.289
Authors: Jessica L Grieves; Gene B Hubbard; Jeff T Williams; John L Vandeberg; Edward J Dick; Juan C López-Alvarenga; Natalia E Schlabritz-Loutsevitch Journal: J Med Primatol Date: 2008-07-30 Impact factor: 0.667
Authors: Derek L Fong; Annie E Torrence; Keith W Vogel; Diane E Stockinger; Veronica Nelson; Robert D Murnane; Audrey Baldessari; LaRene Kuller; Michael Agy; Hans-Peter Kiem; Charlotte E Hotchkiss Journal: Comp Med Date: 2014-02 Impact factor: 0.982
Authors: April L Kendricks; Stanton B Gray; Gregory K Wilkerson; Courtney M Sands; Christian R Abee; Bruce J Bernacky; Peter J Hotez; Maria Elena Bottazzi; Suzanne L Craig; Kathryn M Jones Journal: Comp Med Date: 2020-03-17 Impact factor: 0.982
Authors: Charlotte L Kerr; Tapan Bhattacharyya; Samanta C C Xavier; Juliana H Barros; Valdirene S Lima; Ana M Jansen; Michael A Miles Journal: Parasit Vectors Date: 2016-11-15 Impact factor: 3.876
Authors: Filipe C Reis; Thaís T C Minuzzi-Souza; Mariana Neiva; Renata V Timbó; Igor O B de Morais; Thiago M de Lima; Mariana Hecht; Nadjar Nitz; Rodrigo Gurgel-Gonçalves Journal: Vet Med Sci Date: 2019-11-19